Co., Ltd., the leader of health enrichment products under BRAND’S trademark in Thailand and Asia, in collaboration with the ...

The ACCESS trial is a multicenter, phase 2 trial designed to compare overall survival in patients receiving mismatched unrelated donor peripheral blood stem cells as an allograft source for ...

Greene County Parks and Recreation will unveil its new outdoor fitness playground at 9 a.m. Saturday at Greene County ...

The Alumni Wall of Fame Award recognizes UD graduates for outstanding professional and public service achievements, community ...

James Harrison’s legacy is at the heart of a wild story about canny science, boundless goodwill and an errant blood ...

In one small step for robot-kind — thousands of them, really — humanoid robots ran alongside actual humans in a half-marathon ...

Antibody-drug conjugates continue to show benefits in breast cancer, plus the FDA has fast-tracked an innovative AI tool to help identify pancreatic tumors.

The Community’s Foundation announces names of this year’s scholarship recipients and honors those who made the grants ...

After living kidney donation, projection of renal function may vary by gender, a retrospective cohort study of 174,311 living kidney donors suggested. Over a median 6.7 months, the incidence rate of ...

The global market for Hemodialysis and Peritoneal Dialysis has exhibited a robust growth trajectory, with its valuation increasing from $15,681.81 million in 2019 to an anticipated $22,164.86 million ...

OncoCyte Corporation’s OCX share price has surged by 12.22%, which has investors questioning if this is right time to sell.